Navigation Links
Vaccine May Prevent TB in People With HIV
Date:2/10/2010

Clinical trial results mark 'significant milestone,' expert says

TUESDAY, Feb. 9 (HealthDay News) -- A new vaccine prevents tuberculosis in people with HIV, a new study shows.

Phase III trials of 2,000 HIV-infected people in Tanzania found that the mycobacterium vaccae (MV) vaccine reduced the rate of definite tuberculosis (TB) by 39 percent. The findings have been published online in the journal AIDS.

TB is the most common cause of death among people in developing countries who have HIV/AIDS, and the results of the clinical trials are a "significant milestone," according to principal investigator Dr. Ford von Reyn, director of the DarDar International Programs for the infectious disease and international health section at Dartmouth Medical School, in Hanover, N.H.

"Since development of a new vaccine against tuberculosis is a major international health priority, especially for patients with HIV infection, we and our Tanzanian collaborators are very encouraged by the results," von Reyn said in a news release from the journal's publisher.

The next step, he said, involves improving manufacturing methods so that sufficient quantities of the MV vaccine can be produced for further studies and possible use in patients.

Because people newly infected with HIV risk contracting TB almost immediately, the researchers said, it's important that they get the MV vaccine before they begin taking antiretroviral drugs to fight the HIV infection.

More information

The American Lung Association has more about TB.



-- Robert Preidt



SOURCE: Lippincott Williams & Wilkins, news release, Feb. 2, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
2. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
3. Vaccine Stops Alzheimers Brain Tangles
4. Human Papilloma Virus vaccines may decrease chances of oral cancer
5. U.S. Teens Fall Short on Vaccine Coverage
6. Nasal Anthrax Vaccine Proves Effective in Animal Study
7. Hot ice, measuring depression, perfect invisibility and flu vaccine incentives
8. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
9. Iomai Patch-Based Vaccine Cut Rate of Travelers Diarrhea by 75 Percent in Phase 2 Field Study
10. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
11. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... Modern Consulting Insurance & ... program. Partnering once again with Boys & Girls Clubs of Greater Kansas City, ... area’s very own American Idol. With all proceeds benefitting local worthy causes, donations ...
(Date:8/16/2017)... ... August 16, 2017 , ... The ... a three-year grant totaling $975,000, renewing its funding from the Health Resources and ... , This funding marks, the fourth time the HRSA administration has renewed its ...
(Date:8/16/2017)... ... 16, 2017 , ... LabRoots , the leading provider of educational and ... excited to announce Andrew Ly as the winner of the LabRoots Summer Textbook scholarship, ... , Ly, who is in his third year at the University of California, Los ...
(Date:8/16/2017)... ... , ... With a new PD diagnosis every nine minutes, research is critical ... are awarded through a competitive application process and reviewed by APDA’s Scientific Advisory Board ... in all areas relevant to PD research. The SAB meets annually to review ...
(Date:8/16/2017)... NY (PRWEB) , ... August 16, 2017 , ... Melbourne’s ... year by the prestigious Economist Intelligence Unit’s (EIU) annual Liveability Index. , The Index ... , Since the index began in 2006, Melbourne has consistently come in the top ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... 2017 Diplomat Pharmacy, Inc. (NYSE: DPLO ... as president, effective Aug. 7, 2017. ... pursue other interests and will serve as president emeritus during ... served us in multiple leadership roles since he joined Diplomat ... and has provided decisive, strategic leadership which continues to benefit ...
(Date:8/4/2017)... , Aug. 4, 2017 The search ... shortly after a physician/patient consult has long been the ... was a notable focus of the largest meeting of ... according to healthcare market research firm Kalorama Information.  The ... testing (POCT) offerings or related supplies and software were ...
(Date:8/2/2017)... , Aug. 2, 2017 ... Who,s Who as a Pinnacle Lifetime Professional in ... Key Account Manager at Turing Pharmaceuticals, AG. Her ... troubleshooting and relationship building.                ... more than 25 years of experience as a ...
Breaking Medicine Technology: